Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate

Kestra Medical Techs (NASDAQ: KMTS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.11 percent. The company reported quarterly sales of $22.565 million which beat the analyst consensus estimate of $20.704 million by 8.99 percent.